Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-06-28
1992-02-25
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530313, 530328, 514800, A61K 3702, A61K 3743, C07K 706, C07K 720
Patent
active
050913670
ABSTRACT:
The invention relates to peptides of the formula ##STR1## in which X is absent or is hydrogen or acyl; A is Pgl, de-hydro-Pro, Pro, D-Thi or D-Pgl or represents optionally substituted D-Nal(2), D-Phe or D-Trp; B is His or optionally substituted D-Phe; C is Trp, D-Thi, D-Pal(3) or optionally substituted D-Trp; D is Tyr, Arg of His; E is D-Ser(R.sup.1), .beta.-Asn, .beta.-Asp-OMe, D-Thi or --NH--CH(CH.sub.2 R.sup.2)--CO--; F is Ser(R.sup.1), Leu, Trp or Phe; G is Gly-NH.sub.2, Aza-Gly-NH.sub.2, D-Ala-NH.sub.2 or NH-alkyl; R.sup.1 is glycosyl and R.sup.2 is hydrogen, acyl, aryl or heteroaryl.
The invention also relates to methods for the preparation of these peptides, agents containing them and their use.
REFERENCES:
patent: 4472382 (1984-09-01), Labrie et al.
patent: 4728640 (1988-03-01), Labrie et al.
Chem. Abstr., vol. 110, 58099v (1989).
Synthesis of a Glycotripeptide and a Glycosomatostatin Containing the 3-O-(2-Acetamido-2-Deoxy-.beta.-D-Glucopyranosyl)-L-Serine Residue.
Kolar Cenek
Konig Wolfgang
Sandow Jurgen K.
Hoechst Aktiengesellschaft
Lee Lester L.
LandOfFree
Analogs of gonadoliberin with improved solubility, methods for t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs of gonadoliberin with improved solubility, methods for t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs of gonadoliberin with improved solubility, methods for t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893007